Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 2/20 | 0.67 |
| ▸ | ACACA | Q13085 | 2/20 | 0.67 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.60 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.53 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.53 |
| ▸ | EBP | Q15125 | 8/20 | 0.52 |
| ▸ | HMGCR | P04035 | 2/20 | 0.49 |
| ▸ | CDC25A | P30304 | 4/20 | 0.40 |
| ▸ | CDC25B | P30305 | 4/20 | 0.40 |
| ▸ | CRYAA | P02489 | 1/20 | 0.40 |
| ▸ | CRYAB | P02511 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cycloartanol SCHEMBL13324286 | 1.00 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL1881613 | 1.00 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL30299478 | 1.00 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL455050 | 1.00 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL1881616 | 1.00 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL13801860 | 1.00 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| Cycloartanol SCHEMBL455049 | 1.00 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL13420288 | 0.88 | ACLY (0.70) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL13420286 | 0.87 | ACLY (0.68) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL3479594 | 0.87 | ACLY (0.65) | ACLYACACAPTPN11HSD11B1HSD11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210121383-A1 | COMPOSITION FOR ANTI-AGING | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2021-04-29 | — | — | US | disclosed |
| US-20170319600-A1 | MATRIX METALLOPROTEINASE PRODUCTION INHIBITOR | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2017-11-09 | — | — | US | disclosed |
| US-20170319599-A1 | AGENT FOR PREVENTING OR IMPROVING SYMPTOMS CAUSED BY IMBALANCE OF SEX HORMONES | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2017-11-09 | — | — | US | disclosed |
| US-20170319599-A1 | AGENT FOR PREVENTING OR IMPROVING SYMPTOMS CAUSED BY IMBALANCE OF SEX HORMONES | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2017-11-09 | — | — | US | disclosed |
| US-20170319600-A1 | MATRIX METALLOPROTEINASE PRODUCTION INHIBITOR | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2017-11-09 | — | — | US | disclosed |
| EP-1930014-B1 | AGENT FOR AMELIORATION OF INSULIN RESISTANCE | MORINAGA MILK INDUSTRY CO LTD (JP) | 2017-03-01 | — | — | EP | disclosed |
| CN-106176898-A | A kind of pharmaceutical composition preventing and treating colon cancer | 济南星懿医药技术有限公司 | 2016-12-07 | — | — | CN | disclosed |
| CN-106138563-A | A kind of pharmaceutical composition treating bladder cancer | 济南星懿医药技术有限公司 | 2016-11-23 | — | — | CN | disclosed |
| CN-106138176-A | The pharmaceutical composition for the treatment of colon cancer | 济南星懿医药技术有限公司 | 2016-11-23 | — | — | CN | disclosed |
| CN-106074728-A | A kind of pharmaceutical composition treating colon cancer | 济南星懿医药技术有限公司 | 2016-11-09 | — | — | CN | disclosed |
| US-20100035851-A1 | AGENT FOR IMPROVING INSULIN RESISTANCE | MORINAGA MILK INDUSTRY CO., LTD (JP) | 2010-02-11 | — | — | US | disclosed |
| US-20090054354-A1 | DRUG AND FOOD OR DRINK FOR IMPROVING PANCREATIC FUNCTIONS | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20090054354-A1 | DRUG AND FOOD OR DRINK FOR IMPROVING PANCREATIC FUNCTIONS | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20090004307-A1 | Aloe Vera Extract, Method of Producing Aloe Vera Extract, and Hyperglycemia Improving Agent | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2009-01-01 | — | — | US | disclosed |
| US-20090004307-A1 | Aloe Vera Extract, Method of Producing Aloe Vera Extract, and Hyperglycemia Improving Agent | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2009-01-01 | — | — | US | disclosed |
| EP-1930014-A1 | AGENT FOR AMELIORATION OF INSULIN RESISTANCE | Morinaga Milk Industry Co., Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
| EP-1882472-A1 | DRUGS, FOOD OR DRINK FOR IMPROVING PANCREATIC FUNCTIONS | Morinaga Milk Industry Co., Ltd. (JP) | 2008-01-30 | — | — | EP | disclosed |
| US-20070196435-A1 | Drug and food or drink for improving hyperglycemia | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2007-08-23 | — | — | US | disclosed |
| US-20070196435-A1 | Drug and food or drink for improving hyperglycemia | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2007-08-23 | — | — | US | disclosed |
| EP-1795200-A1 | MEDICINE AND FOOD/BEVERAGE FOR AMELIORATING HYPERGLYCEMIA | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2007-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035851-A1 | AGENT FOR IMPROVING INSULIN RESISTANCE | GPR119, IRS1, LIPE | ACLY 159/4885ACACA 290/4885PTPN11 1140/4885 |
| US-20170319599-A1 | AGENT FOR PREVENTING OR IMPROVING SYMPTOMS CAUSED BY IMBALANCE OF SEX HORMONES | SHBG, NR5A1, CYP19A1 | ACLY 2891/4885ACACA 1746/4885PTPN11 2496/4885 |
| US-20090054354-A1 | DRUG AND FOOD OR DRINK FOR IMPROVING PANCREATIC FUNCTIONS | GPR119, PNLIP, AMY2A | ACLY 1113/4885ACACA 449/4885PTPN11 3615/4885 |
| US-20070196435-A1 | Drug and food or drink for improving hyperglycemia | GPR119, SLC2A9, GCKR | ACLY 565/4885ACACA 305/4885PTPN11 3489/4885 |
| US-20090004307-A1 | Aloe Vera Extract, Method of Producing Aloe Vera Extract, and Hyperglycemia Improving Agent | ALOX12, ALOX15, ALOX15B | ACLY 620/4885ACACA 95/4885PTPN11 1944/4885 |
| US-20210121383-A1 | COMPOSITION FOR ANTI-AGING | GLA, GLB1, LIMS1 | ACLY 1282/4885ACACA 119/4885PTPN11 2857/4885 |
| US-20170319600-A1 | MATRIX METALLOPROTEINASE PRODUCTION INHIBITOR | MMP17, MMP7, MMP16 | ACLY 3023/4885ACACA 964/4885PTPN11 3925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.